Dr. Colombel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 E 98th St
New York, NY 10029Phone+1 212-241-4299Fax+1 212-426-5099
Education & Training
- OtherClass of 1984
Certifications & Licensure
- NY State Medical License 2013 - 2025
Publications & Presentations
PubMed
- 364 citationsVedolizumab as induction and maintenance therapy for Crohn's disease.William J Sandborn, Brian G Feagan, Paul Rutgeerts, Stephen Hanauer, Jean-Frédéric Colombel
The New England Journal of Medicine. 2013-08-22 - 1071 citationsCrohn's diseaseJoana Torres, Saurabh Mehandru, Jean-Frederic Colombel, Laurent Peyrin-Biroulet
Lancet. 2017-04-29 - 223 citationsA Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s DiseaseWilliam J. Sandborn, Subrata Ghosh, Julián Panés, Ivana Vranic, Wenjin Wang
Clinical Gastroenterology and Hepatology. 2014-09-01
Press Mentions
- Growing up with a Dog Might Protect Against Crohn's DiseaseMay 26th, 2022
- Vedolizumab Doesn’t Increase Risk of C Diff in Ulcerative ColitisDecember 28th, 2021
- Very Few Patients with IBD Get Early VedolizumabDecember 28th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: